Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 13, 2012 - Issue 17
Submit an article Journal homepage
471
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Black/African American patients with type 2 diabetes mellitus: study design and baseline patient characteristics from a randomized clinical trial of linagliptin

James ThrasherMedical Investigations, Inc., 500 South University, Suite 615, Little Rock, AR 72205, USA+1 501 666 3666; +1 501 663 0491; [email protected]
,
Kristen DanielsBoehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
,
Sanjay PatelBoehringer Ingelheim, Bracknell, UK
&
Jacqueline WhetteckeyBoehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
Pages 2443-2452 | Published online: 08 Nov 2012

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Avivit Cahn & Itamar Raz. (2013) Emerging gliptins for type 2 diabetes. Expert Opinion on Emerging Drugs 18:2, pages 245-258.
Read now

Articles from other publishers (7)

Wenjia Yang, Xiaoling Cai, Simin Zhang, Xueyao Han & Linong Ji. (2020) Dipeptidyl peptidase‐4 inhibitor treatment and the risk of bullous pemphigoid and skin‐related adverse events: A systematic review and meta‐analysis of randomized controlled trials. Diabetes/Metabolism Research and Reviews 37:3.
Crossref
Clement Lo, Tadashi Toyama, Ying Wang, Jin Lin, Yoichiro Hirakawa, Min Jun, Alan Cass, Carmel M Hawley, Helen Pilmore, Sunil V Badve, Vlado Perkovic & Sophia Zoungas. (2018) Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database of Systematic Reviews.
Crossref
Subodh Verma, Ronald M. Goldenberg, Deepak L. Bhatt, Michael E. Farkouh, Adrian Quan, Hwee Teoh, Kim A. Connelly, Lawrence A. Leiter & Jan O. Friedrich. (2017) Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis. CMAJ Open 5:1, pages E152-E177.
Crossref
Tiansheng Wang, Fei Wang, Junwen Zhou, Huilin Tang & Sharon Giovenale. (2016) Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials. Diabetes/Metabolism Research and Reviews 32:8, pages 843-857.
Crossref
Shikhar Agarwal, Akhil Parashar & Venu Menon. (2014) Meta-Analysis of the Cardiovascular Outcomes with Dipeptidyl Peptidase 4 Inhibitors: Validation of the Current FDA Mandate. American Journal of Cardiovascular Drugs 14:3, pages 191-207.
Crossref
James Thrasher, Kristen Daniels, Sanjay Patel, Jacqueline Whetteckey & Hans-Juergen Woerle. (2014) Efficacy and Safety of Linagliptin in Black/African American Patients with Type 2 Diabetes: A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study. Endocrine Practice 20:5, pages 412-420.
Crossref
David Kountz. (2013) The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups. Advances in Therapy 30:12, pages 1067-1085.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.